Literature DB >> 27220762

Peritoneal dissemination in early gastric cancer: importance of the lymphatic route.

Masao Yoshida1,2, Takashi Sugino3, Kimihide Kusafuka3, Takashi Nakajima3, Rie Makuuchi4, Masanori Tokunaga4, Yutaka Tanizawa4, Etsuro Bando4, Taiichi Kawamura4, Masanori Terashima4, Noboru Kawata5, Masaki Tanaka5, Naomi Kakushima5, Kohei Takizawa5, Hiroyuki Ono5.   

Abstract

The current paradigm concerning the mechanism of peritoneal dissemination of gastric cancer is that it occurs through an invasive process in which cancer cells directly penetrate the gastric wall and exfoliate into the peritoneal cavity. However, some experimental studies suggest the lymphatic route as an alternative. We present five early gastric cancer cases, which support this alternative pathway of peritoneal dissemination without direct invasion in the serosa. We investigated all patients with early gastric cancer who underwent curative gastrectomy between September 2002 and February 2015 at the Shizuoka Cancer Center, Japan. We examined them by intraoperative peritoneal lavage cytology and frozen section diagnosis of peritoneal nodules during laparotomy. Peritoneal dissemination was defined as peritoneal metastasis by positive cytology or histological diagnosis. Among 1509 early gastric cancers, five cases (0.3 %, 95 % CI 0.1-0.8 %) presented peritoneal dissemination detected by lavage cytology and frozen section diagnosis of peritoneal nodules. Histological examination revealed that the primary tumors invaded the submucosal layer using the lymphatic route, through which they metastasized to regional lymph nodes. Our data indicate that gastric cancer may give rise to peritoneal dissemination even at an early stage, probably through the lymphatic route without direct invasion into the serosa.

Entities:  

Keywords:  Gastric cancer; Lymphatic metastasis; Lymphatic vessels; Neoplasm seeding; Neoplastic processes

Mesh:

Year:  2016        PMID: 27220762     DOI: 10.1007/s00428-016-1960-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  30 in total

1.  Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy.

Authors:  Olivier Glehen; François Noel Gilly; Catherine Arvieux; Eddy Cotte; Florent Boutitie; Baudouin Mansvelt; Jean Marc Bereder; Gérard Lorimier; François Quenet; Dominique Elias
Journal:  Ann Surg Oncol       Date:  2010-03-25       Impact factor: 5.344

2.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Gastric cancer: a 25-year review.

Authors:  W H Allum; J W Fielding
Journal:  Br J Surg       Date:  1990-03       Impact factor: 6.939

4.  Causes of death and recurrence after surgery for early gastric cancer.

Authors:  S Guadagni; M Catarci; T Kinoshitá; M Valenti; G De Bernardinis; M Carboni
Journal:  World J Surg       Date:  1997-05       Impact factor: 3.352

5.  Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice.

Authors:  A Hagiwara; T Takahashi; K Sawai; H Taniguchi; M Shimotsuma; S Okano; C Sakakura; H Tsujimoto; K Osaki; S Sasaki
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

6.  Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.

Authors:  Irene Thomassen; Yvette R van Gestel; Bert van Ramshorst; Misha D Luyer; Koop Bosscha; Simon W Nienhuijs; Valery E Lemmens; Ignace H de Hingh
Journal:  Int J Cancer       Date:  2013-08-05       Impact factor: 7.396

7.  Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma.

Authors:  E Bando; Y Yonemura; Y Takeshita; K Taniguchi; T Yasui; Y Yoshimitsu; S Fushida; T Fujimura; G Nishimura; K Miwa
Journal:  Am J Surg       Date:  1999-09       Impact factor: 2.565

8.  Early gastric cancer: follow-up after gastrectomy in 159 patients.

Authors:  S Guadagni; P I Reed; B J Johnston; G De Bernardinis; M Catarci; M Valenti; F di Orio; M Carboni
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

9.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.

Authors:  Xiao-Jun Yang; Chao-Qun Huang; Tao Suo; Lie-Jun Mei; Guo-Liang Yang; Fu-Lin Cheng; Yun-Feng Zhou; Bin Xiong; Yutaka Yonemura; Yan Li
Journal:  Ann Surg Oncol       Date:  2011-03-23       Impact factor: 5.344

10.  Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database.

Authors:  Baojun Huang; Zhe Sun; Zhenning Wang; Chong Lu; Chengzhong Xing; Bo Zhao; Huimian Xu
Journal:  BMC Cancer       Date:  2013-02-04       Impact factor: 4.430

View more
  8 in total

1.  The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis.

Authors:  Beate Rau; Andreas Brandl; Peter Thuss-Patience; Fabian Bergner; Wieland Raue; Alexander Arnold; David Horst; Johann Pratschke; Matthias Biebl
Journal:  Gastric Cancer       Date:  2019-05-07       Impact factor: 7.370

2.  Development and Biological Analysis of a Novel Orthotopic Peritoneal Dissemination Mouse Model Generated Using a Pancreatic Ductal Adenocarcinoma Cell Line.

Authors:  Kazuyoshi Yanagihara; Takanori Kubo; Keichiro Mihara; Takeshi Kuwata; Atsushi Ochiai; Toshio Seyama; Hiroshi Yokozaki
Journal:  Pancreas       Date:  2019-03       Impact factor: 3.327

3.  The Morphological Analysis of Cells in the Peritoneal Washing Fluids of Patients with Gastric Cancer.

Authors:  Ren-Peng Jiang; Xue-Jiao Xiong; Xue-Shan Qiu; En-Hua Wang; Guang-Ping Wu
Journal:  Cell Transplant       Date:  2019-08-01       Impact factor: 4.064

4.  Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer.

Authors:  Shingo Togano; Masakazu Yashiro; Yuichiro Miki; Yurie Yamamato; Tomohiro Sera; Yukako Kushitani; Atsushi Sugimoto; Shuhei Kushiyama; Sadaaki Nishimura; Kenji Kuroda; Tomohisa Okuno; Mami Yoshii; Tatsuro Tamura; Takahiro Toyokawa; Hiroaki Tanaka; Kazuya Muguruma; Sayaka Tanaka; Masaichi Ohira
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

5.  A Nomogram Based on Clinicopathologic Features and Preoperative Hematology Parameters to Predict Occult Peritoneal Metastasis of Gastric Cancer: A Single-Center Retrospective Study.

Authors:  Chao Yang; Yujie Yang; Xiaodong Huang; HuaLi Li; Huangrong Cheng; Shilun Tong; Yongbin Zheng
Journal:  Dis Markers       Date:  2020-12-09       Impact factor: 3.434

6.  NORAD-sponged miR-378c alleviates malignant behaviors of stomach adenocarcinoma via targeting NRP1.

Authors:  Yongjun Hu; Ming Luo
Journal:  Cancer Cell Int       Date:  2022-02-14       Impact factor: 5.722

7.  Potential for Peritoneal Metastasis after Gastric Perforation Induced by Endoscopic Submucosal Dissection of Early Gastric Cancer.

Authors:  Bong Eun Lee
Journal:  Gut Liver       Date:  2019-09-15       Impact factor: 4.519

Review 8.  Molecular mediators of peritoneal metastasis in pancreatic cancer.

Authors:  Leela Rani Avula; Brendan Hagerty; Christine Alewine
Journal:  Cancer Metastasis Rev       Date:  2020-08-11       Impact factor: 9.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.